Yanagita T, Wakasa Y, Kiyohara H
Pharmacol Biochem Behav. 1980 Jan;12(1):155-61. doi: 10.1016/0091-3057(80)90430-x.
The drug dependence potential of viloxazine was tested in 5 experiments on rhesus monkeys. In gross behavioral observation of normal monkeys the acute CNS effects of the drug were found to be very weak. Decrement of spontaneous motor activity and occasional eye-closing were observed with single doses higher than 16 mg/kg IV, IM and 128 mg/kg PO, while convulsions and death occured at 64 mg/kg IV and IM. Viloxazine did not suppress the morphine and barbital withdrawal signs in monkeys that had been made physically dependent on these drugs and withdrawal. In the test for physical dependence by repeated administration of the drug at 16 mg/kg IM twice daily for 31 days in normal monkeys, no observable withdrawal sign was developed in the naloxone precipitation and natural withdrawal tests. In intravenous self-administration experiments, a weak reinforcing effect was demonstrated in some monkeys, but the effect was extremely weak. Thus, viloxazine was found to be physical dependence-free and its overall dependence potential was regarded as very low.
在5项针对恒河猴的实验中测试了维洛沙嗪的药物依赖性潜力。在对正常猴子的总体行为观察中,发现该药物的急性中枢神经系统作用非常微弱。静脉注射、肌肉注射单剂量高于16mg/kg以及口服单剂量高于128mg/kg时,可观察到自发运动活动减少和偶尔闭眼,而静脉注射和肌肉注射64mg/kg时会出现惊厥和死亡。维洛沙嗪不会抑制已对这些药物产生身体依赖性并进行戒断的猴子的吗啡和巴比妥戒断症状。在正常猴子中,通过每天两次肌肉注射16mg/kg该药物,连续31天重复给药进行身体依赖性测试时,在纳洛酮激发试验和自然戒断试验中均未出现可观察到的戒断症状。在静脉自我给药实验中,一些猴子表现出微弱的强化作用,但这种作用极其微弱。因此,发现维洛沙嗪无身体依赖性,其总体依赖性潜力被认为非常低。